Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Metabolomics and integrated network analysis reveal roles of endocannabinoids and large neutral amino acid balance in the ayahuasca experience.
Madrid-Gambin F, Gomez-Gomez A, Busquets-Garcia A, Haro N, Marco S, Mason NL, Reckweg JT, Mallaroni P, Kloft L, van Oorsouw K, Toennes SW, de la Torre R, Ramaekers JG, Pozo OJ. Madrid-Gambin F, et al. Among authors: busquets garcia a. Biomed Pharmacother. 2022 May;149:112845. doi: 10.1016/j.biopha.2022.112845. Epub 2022 Mar 24. Biomed Pharmacother. 2022. PMID: 35339828 Free article.
Targeting the endocannabinoid system in the treatment of fragile X syndrome.
Busquets-Garcia A, Gomis-González M, Guegan T, Agustín-Pavón C, Pastor A, Mato S, Pérez-Samartín A, Matute C, de la Torre R, Dierssen M, Maldonado R, Ozaita A. Busquets-Garcia A, et al. Nat Med. 2013 May;19(5):603-7. doi: 10.1038/nm.3127. Epub 2013 Mar 31. Nat Med. 2013. PMID: 23542787
Cannabinoid type-1 receptor blockade restores neurological phenotypes in two models for Down syndrome.
Navarro-Romero A, Vázquez-Oliver A, Gomis-González M, Garzón-Montesinos C, Falcón-Moya R, Pastor A, Martín-García E, Pizarro N, Busquets-Garcia A, Revest JM, Piazza PV, Bosch F, Dierssen M, de la Torre R, Rodríguez-Moreno A, Maldonado R, Ozaita A. Navarro-Romero A, et al. Neurobiol Dis. 2019 May;125:92-106. doi: 10.1016/j.nbd.2019.01.014. Epub 2019 Jan 25. Neurobiol Dis. 2019. PMID: 30685352
Metabolic Messengers: endocannabinoids.
Busquets-García A, Bolaños JP, Marsicano G. Busquets-García A, et al. Nat Metab. 2022 Jul;4(7):848-855. doi: 10.1038/s42255-022-00600-1. Epub 2022 Jul 11. Nat Metab. 2022. PMID: 35817852 Review. No abstract available.
A phase 1, randomized double-blind, placebo controlled trial to evaluate safety and efficacy of epigallocatechin-3-gallate and cognitive training in adults with Fragile X syndrome.
de la Torre R, de Sola S, Farré M, Xicota L, Cuenca-Royo A, Rodriguez J, León A, Langohr K, Gomis-González M, Hernandez G, Esteba S, Del Hoyo L, Sánchez-Gutiérrez J, Cortés MJ, Ozaita A, Espadaler JM, Novell R, Martínez-Leal R, Milá M, Dierssen M; TESXF Study Group. de la Torre R, et al. Clin Nutr. 2020 Feb;39(2):378-387. doi: 10.1016/j.clnu.2019.02.028. Epub 2019 Mar 25. Clin Nutr. 2020. PMID: 30962103 Clinical Trial.
46 results